KR20150010551A - Compositions for deodorant - Google Patents
Compositions for deodorant Download PDFInfo
- Publication number
- KR20150010551A KR20150010551A KR1020130152361A KR20130152361A KR20150010551A KR 20150010551 A KR20150010551 A KR 20150010551A KR 1020130152361 A KR1020130152361 A KR 1020130152361A KR 20130152361 A KR20130152361 A KR 20130152361A KR 20150010551 A KR20150010551 A KR 20150010551A
- Authority
- KR
- South Korea
- Prior art keywords
- body odor
- extracts
- group
- component
- aluminum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Abstract
Description
The present invention relates to a reactive body odor inhibitory component and a body odor inhibitory composition to which a functional group binding to a protein is bound.
Restricted deodorization is generally applied to the body to suppress the occurrence of sweating of the person and to suppress the unpleasantness of the body to clean the body, to beautify it, to increase the attractiveness, to change the appearance, or to keep the skin and hair healthy , Scattering, and the like.
Related quasi-drugs are defined as not having the purpose of use such as affecting the structure and function of the body, rather than being used for the treatment or prevention of diseases, even though the action on the human body is smaller than that of the cosmetics.
In general, the limiting agent is a product for suppressing the occurrence of sweat, and the deodorant is a product for suppressing the unpleasant odor of the body. However, since the unpleasant body odor is caused by the odor of the product decomposed by the microorganism of the secretion of the sweat glands, the restricting agent can be said to have a function of restraining displeasure by suppressing perspiration which causes unpleasant body odor by the restriction function. Deodorant products, which have been approved as quasi-drugs in Korea up to now, are deodorants in name, but they can be said to be limited deodorants with limited function.
Sweating in the human body is very important in terms of physiological function, but often has a bad influence on the skin. Occurrence of fever, and fever are representative, and it is necessary to prevent the hygienic and cosmetic aspects of the skin.
General methods of restriction and deodorization include suppressing the occurrence of sweating from the echinacea and apocrine glands by using aluminum compounds such as chlorohydroxy aluminum, allantoin chlorohydroxy aluminum, allantoin dihydroxy aluminum, or zinc p-phenol sulfonate. A method of masking the smell by use of fragrance or odecoron, and the like are used.
Restriction and deodorant compositions generally include products such as cleansing, tidying up, protecting products for bodily and skin care, bass, point, bath, restriction, deodorant, hair loss, hair removal and the like. Restrictions for hair, scalp and deodorant composition include first hair restraints such as cleansing, treatment, regular hair, fur, hair, decolorization, and deodorant products and hair restraint and deodorant products such as wool, hair growth, Directional restriction with function and deodorization products.
Typical raw materials used to formulate these limitations and deodorization products are oily materials such as oils, waxes, hydrocarbons, higher fatty acids, higher alcohols, ester oils, silicone oils, anionic, cationic, amphoteric and nonionic surfactants , A polymer compound used as a moisturizing agent, a thickening agent and a film former, an ultraviolet absorbing and blocking agent, an antioxidant, a sequestering agent, a coloring material including a dye and a pigment, a fragrance, a preservative and the like.
In addition, the limiting and deodorizing main components include aluminum compounds such as chlorohydroxy aluminum, allantoin chlorohydroxy aluminum, allantoin dihydroxy aluminum, or zinc p-phenol sulfonate, benzalkonium chloride, triclosan, . Examples of the additional effective ingredient include zinc oxide, zinc lactate, allantoin hydroxy aluminum, magnesium chloride, aluminum sulfate, zinc sulfochloride, tannic acid, citric acid, lactic acid and other astringent agents for tightening the skin, And halo compounds which deodorize odor molecules such as cyclodextrins and derivatives, cooker bitriles and derivatives, and the like.
In addition, agents for preventing body odor include pharmaceutical agents for preventing body odor such as aluminum chloride, aluminum sulfate, potassium sulfate and zinc oxide, bactericides such as benzethonium chloride, halocaran, chlorhexidine hydrochloride, and deodorant such as zinc oxide.
Oral medicinal materials may also include oral pharmaceutical ingredients such as anti-bad breathing ingredients such as sodium chlorophyllin, and tobacco skin-removing ingredients such as polyethylene glycol.
However, when used as a skin and the like with such restriction and deodorant ingredients, it only provides a temporary effect until the next cleaning after the treatment, but there is always the hassle of reprocessing after cleaning.
Patent Document 1 discloses a non-aqueous personal care product for skin or hair, which comprises a non-water-based functional group capable of forming a covalent bond with a hair or a protein residue on the surface of a skin, such as carbonate, aldehyde, propionaldehyde, But are not limited to, butylaldehyde, nitrophenyl carbonate, aziridine, isocyanate, thiocyanate, epoxide, tresylate, succinimide, A hydroxysuccinimidyl ester, an imidazole, an oxycarbonylamidazole, an imine, a thiol, a maleimide, a vinylsulfone, For example, ethyleneimine, thioether, acrylonitrile, acrylic acid or methacrylic ester, (Wherein R is any one selected from the group consisting of alkyl, aryl, aralkyl, cyclic and unsaturated rings, and X is I, Br or Cl) represented by the following formula And a water-based part containing a conditioning component having at least one selected from the group consisting of the above-mentioned various kinds of functional groups, (1.9 to 3.1%) and skin keratin (3.1 to 6.9%) in the amino acids of the proteins constituting the hair or the skin, ~ 18%) and skin keratin (2.3 ~ 3.8%) are targeted and reacted, so that the reaction efficiency is lowered. There is a problem in that it must be synthesized.
It is an object of the present invention to provide a composition for suppressing body odor, which is capable of continuously imparting a semi-permanent body odor suppressing effect without damaging skin or hair.
As means for solving the above problems, the present invention provides a body odor inhibiting composition comprising a carbodiimide compound and a body odor control component.
As another means for solving the above-mentioned problems, the present invention provides a body odor inhibiting component, which comprises at least one compound selected from carbodiimide, imidoester, aryl azide, diazirine, hydroxymethylphosphine, pentafluorophenyl ester, pyridyl disulfide, At least one hair selected from the group consisting of hydroxysuccinimide ester, alkoxyamine, hydrazide, haloacetyl, and azide, or a functional covalent bond with a protein on the surface of the skin.
As another means for solving the above-mentioned problems, the present invention provides a composition for suppressing body odor comprising the above-mentioned reactive body odor control component.
The composition for suppressing body odor according to the present invention contains a reactive body-suppressing component and / or a carbodiimide compound into which a specific functional group capable of covalent bonding with the skin or hair protein residue is introduced, And provides semi-permanent body odor suppression effect.
The present invention relates to a body odor inhibiting composition comprising a carbodiimide compound and an anti-body-suppressing component.
The composition for suppressing body odor according to the present invention can be obtained by, for example, reacting a carbodiimide compound with a known body odor inhibiting component to form a covalent bond with a skin or hair protein through a reactive body odor inhibiting component having a carbodiimide group attached thereto Thereby maximizing the body odor inhibiting effect.
The carbodiimide compound may be used in an amount of 0.001 to 10 parts by weight, 0.01 to 7 parts by weight, or 0.1 to 5 parts by weight based on 100 parts by weight of the total composition. When the content is less than 0.001 part by weight, there is a problem that continuous body odor inhibitory effect is hardly exhibited. When the content exceeds 10 parts by weight, carbodiimide compound excessively present at the reaction site existing in the skin does not react with skin or fiber , There is a problem that it can act as a component to be lost, which does not help to improve persistence.
In the present invention, the term " body odor inhibiting effect " means a function of preventing body odor, which is a malodor of a product decomposed by microorganisms, from sweat gland secretions or suppressing the occurrence of sweat which is a cause of body odor.
Examples of the body odor inhibiting component used in the present invention include aluminum compounds such as chlorohydroxy aluminum, allantoin chlorohydroxy aluminum, allantoin dihydroxy aluminum, aluminum chloride, aluminum potassium sulfate, benzalkonium chloride, Extracts of ginseng, extracts of ginseng, extracts of ginseng, extracts of ginseng, extracts of ginkgo biloba, extracts of ginseng extract, licorice extract, seaweed extracts, ginseng extracts, An extract of green tea, a green tea extract, a peony extract, a green tea extract, and a peony extract.
Examples of the additional effective ingredient include zinc oxide, zinc lactate, allantoin hydroxy aluminum, magnesium chloride, aluminum sulfate, zinc sulfochloride, tannic acid, citric acid, lactic acid and other astringent agents for tightening the skin, And halo compounds which deodorize odor molecules such as cyclodextrins and derivatives, cooker bitriles and derivatives can be used.
Oral medicinal materials may also include mouthwash preventing ingredients such as sodium chlorophyllin, oral pharmaceutical ingredients including a cigarette skin removing ingredient such as polyethylene glycol, and the like.
The body odor control component is preferably used in an amount of 0.001 to 50 parts by weight, 0.001 to 30 parts by weight, 0.01 to 10 parts by weight, or 0.1 to 5 parts by weight based on 100 parts by weight of the total composition. When the amount is less than 0.001 part by weight, there is a problem of effective performance limit. When the amount is more than 50 parts by weight, formulation and formulation stability are problematic.
Particularly, in the present invention, the body-odor inhibiting component can increase the reaction efficiency with the carbodiimide compound by including a carboxyl group or an amine group in the molecule.
In addition, in the present invention, the body-odor inhibiting component may be one having a functional group capable of covalently bonding to protein residues on the skin or hair surface.
The functional groups covalently bonded to the protein include carbodiimide, imidoesters, aryl azides, diazylines, hydroxymethylphosphines, pentafluorophenyl esters, pyridyl disulfides, sulfo-hydroxysuccinimide esters, alkoxy amines, The present invention also relates to a process for the preparation of a medicament for the treatment and / or prophylaxis of a disease or condition selected from the group consisting of hydrazide, haloacetyl, azide, carbonate, aldehyde, propionaldehyde, butylaldehyde, nitrophenylcarbonate, aziridine, isocyanate, thiocyanate, epoxide, May be at least one selected from the group consisting of imidazole, oxycarbonylamidazole, imine, thiol, maleimide, vinylsulfone, ethyleneimine, thioether, acrylonitrile, acrylic acid or methacrylic acid ester, disulfide and ketone , But is not limited thereto.
In addition, the protein may comprise reactive residues of thiol, hydroxyl, carboxyl or amine.
The carbodiimide compound is generally referred to as a compound containing a structure represented by the following formula (1) in the molecule.
[Chemical Formula 1]
-N = C = N-
The carbodiimide compound preferably has at least 1 to 1000 structures represented by the formula (1), more preferably 1 to 100 structures represented by the formula (1) It is more preferable that the structure includes 1 to 10 structures in the molecule.
In this case, if the number of the carbodiimide groups represented by the formula (1) exceeds 1,000 in one molecule, the viscosity of the starting material is too large, the molecular weight is excessively large, the reaction position where the reaction can be performed becomes excessively large, The molecule having the bodymide group becomes too large, and the efficiency is lowered by blocking the portion showing the functional effect of the molecule having the substantial function.
In the present invention, a specific example of the carbodiimide compound may be a compound represented by the following formula (2), wherein n is 4 and m is 11 in the following formula (2): benzene, 1,3, Isocyanato-1-methylethyl) -, homopolymer, polyethylene glycol mono-ether-block (benzene, 1-isocyanato- Me-ether-blocked (hereinafter referred to as polymeric carbodiimide compound of formula (2)).
(2)
In the above formula (2), n is 1 to 100 and m is 1 to 100.
Another example of the carbodiimide compound in the present invention is 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide, which is a compound represented by the following formula (3) carbodiimide or 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide.HCl may be used.
(3)
In one preferred embodiment of the composition for suppressing body odor according to the present invention, the body-odor inhibiting component having a carboxyl group is made into a form of a reactive ester body-suppressing component having a direct bioactivity, or skin keratin (15.5 to 23.5%) or hair (Ex., Aspartic acid, glutamic acid) existing in an excessive amount in a reaction mixture (e.g., 21.9%) is reacted with a carbodiimide compound that can be targeted by the body-odor inhibiting component including an amine group, ) Can be made to increase the reaction efficiency, thereby remarkably increasing the effect. In addition, it is also possible to use carbodiimides, imidoesters, aryl azides, diazylines, hydroxymethylphosphines, pentafluorophenyl esters, pyridyl disulfides, sulfo-hydroxysuccinimide esters, alkoxy The effect can be further enhanced by using a body-odor inhibiting component containing a functional group such as amine, hydrazide, haloacetyl, or azide in the molecule.
As a more preferable embodiment, a polymeric carbodiimide compound of formula (2) or 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide . A carbodiimide compound such as 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide.HCl is firstly reacted to form a reactive ester, and a bacteriostatic component having an amine in the molecule in addition to the reactive ester functional group formed Or by reacting with amine on the skin or hair surface, an excellent body odor inhibiting effect can be obtained. The reaction is preferably carried out at a pH of 2 to 10, more preferably at a pH of 3 to 9, most preferably at an acidic to slightly acidic pH of about 4 to 5 The reaction efficiency can be increased most. The reaction is completed within 1 minute to 30 minutes.
The reaction scheme 1 shows a reaction scheme in which the body-suppressing component molecule having a carboxyl group reacts with a carbodiimide-based compound in a primary reaction to form a reactive ester, and then reacts with an amino acid in the living body having an amine residue to form a covalent bond.
[Reaction Scheme 1]
In the following Reaction Scheme 2, asparaginic acid and glutamic acid, which are carboxylamino group-bearing biological amino acids on the surface of proteins of skin or hair, first react with a carbodiimide compound to form a reactive ester, and then react with a body-inhibiting component having an amine residue to form a covalent bond The reaction scheme is shown in Fig.
[Reaction Scheme 2]
The carbodiimide compound enhances the reaction efficiency of the skin or hair protein and the body odor inhibiting component, so that the reactive body odor inhibitory component bound to the skin or hair does not fall off well during general washing due to shampoo or soap, The skin or hair can be kept attached.
The present invention also relates to a method for inhibiting the body odor of a body odor composition comprising adding to a body odor inhibiting component a carbodiimide group, an imidoester, an aryl azide, a diazirine, a hydroxymethylphosphine, a pentafluorophenyl ester, a pyridyl disulfide, a sulfo-hydroxysuccinimide ester, The present invention relates to a process for the preparation of a pharmaceutical composition which comprises administering an effective amount of a compound selected from the group consisting of an amine, hydrazide, haloacetyl, azide, carbonate, aldehyde, propionaldehyde, butylaldehyde, nitrophenylcarbonate, aziridine, isocyanate, thiocyanate, epoxide, At least one member selected from the group consisting of diesters, imidazoles, oxycarbonylamidazoles, imines, thiols, maleimides, vinylsulfones, ethyleneimines, thioethers, acrylonitriles, acrylic acid or methacrylic acid esters, disulfides and ketones May contain a reactive body-odor inhibiting component coupled with a functional group covalently bonded to the protein have.
For example, as shown in Scheme 1, the carbodiimide compound may be reacted with a carbodiimide group to form a body-suppressing component. In addition, the present invention may include a body odor inhibiting composition comprising the above-mentioned reactive body odor control component.
In order to increase the secondary effects of the composition for suppressing body odor according to the present invention, fatty acids such as palmitic acid and stearic acid, fatty alcohols, and long-chain alkyl quaternary ammonium salts of straight chain and branched chain are cationized When mixed with a cationic polymer such as a surfactant, cationized cellulose, cationic guar, cationized polyvinylpyrrolidone, silicone, etc., formulation can be facilitated. In addition, for formulation, auxiliary ingredients such as a solvent, a surfactant, a thickener, a stabilizer, a preservative, a colorant, a pH adjuster, a sequestering agent, a colorant, a pearlizing agent, can do. The ingredients for the formulation may be used in an amount of 40 to 99 parts by weight based on 100 parts by weight of the total composition.
The composition for suppressing body odor according to the present invention can be used for the formulation of a body composition for suppressing body odor containing a component having a body odor suppressing function having a functional group. Examples of applications of skin products include cosmetics (such as lotion, serum, essence, lotion, cream), color cosmetics (makeup base, foundation, powder, eye shadow, lip gloss, lipstick, lip balm, etc.) (Cleansing lotion, cleansing cream, cleansing gel, pack, mask, soap, cleansing tissue, etc.), sun care Hair cosmetics, body cosmetics (body lotion, shower gel, body cream, body oil, etc.), and the hair can also contain shampoo, rinse, trimming, hair pack, hair essence, wax, All preparations may be included.
More preferably, the body odor inhibitory composition according to the present invention contains a body odor inhibitory component including a carbodiimide compound and a reactive functional group, and when the activity of the above agent is lowered in the aqueous system, It may be easier to maintain the activity in the buffer solution before the reaction, or may be mixed with a buffer for pH control just before use, or may be brought into contact with water during the washing process. Examples of non-aqueous formulations include liquid, sheet, powder, tablet, oil, wax, ampoule, gel and the like which are used as ordinary non-aqueous cosmetic preparations. In addition, the carbodiimide compound and the body odor inhibitory component can be formulated in a single form of encapsulated form or in two separate forms, respectively. In addition, a method of blocking a derivative in which a functional group having a reactivity and a component having an anti-body function are combined through encapsulation from water can also be used.
In order to enhance the body odor inhibitory effect having a functional group in the body-odor suppressing composition according to the present invention, it is preferred to use a mixture of a 2-base acid ester oil such as dioctyl succinate, dioctyl adipate, diethyl sebacate and the like and a polyol, a polyethylene glycol, , Hexylene glycol, butane diol and their isomers, glycerol, benzyl alcohol, ethoxydiglycol and derivatives thereof. The above-mentioned solvents increase the permeability of the skin or hair and are used as a solvent of a poorly soluble substance. More preferably, the solvent used for enhancing the activity-maintaining effect of the body-suppressing component having a functional group is diethyl sebacate, ethoxy glycol, bis-ethoxy glycol cyclohexane 1,4-dicarboxylate and the like.
Hereinafter, the present invention will be described in detail by the following examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
Example 1 to 2 and Comparative Example One
The body odor inhibiting compositions of Examples 1 to 2 and Comparative Example 1 were prepared by the compositions and contents shown in the following Table 1, and the prepared composition was used for 10 days for three days on the axilla twice a day (5 excellent, 4 slightly superior, 3 no difference, 2 no effect, 1 very no effect) on the 5-point scale (1 excellent effect).
The results of the experiments of Examples 1 and 2 and Comparative Example 1 (Table 2) and Examples 1 and 2, which include carbodiimide, compared with Comparative Example 1 which does not include carbodiimide, And showed excellent body odor preventing effect.
Formulation example : Deodorant Produce
Deodorant was prepared in accordance with the usual deodorant production method with the components and contents shown in Table 3 below.
Claims (9)
Wherein the body-odor suppressing component comprises a carboxyl group or an amine group in the molecule.
Wherein the body odor control component is selected from the group consisting of chlorohydroxy aluminum, allantoin chlorohydroxy aluminum, allantoin dihydroxy aluminum, aluminum chloride, aluminum compounds such as aluminum potassium sulfate, halogenated benzethonium, halocaran, chlorhexidine hydrochloride, zinc oxide, Extracts of ginkgo biloba, extracts of ginkgo biloba, extracts of ginkgo biloba, extracts of licorice, extracts of moss, extracts of moss, extracts of moss, ginkgo biloba extract, ginkgo biloba extract, , Bamboo salt, grapefruit extract, green tea extract and peony extract.
Wherein the body odor inhibiting component has a functional group capable of being covalently bonded to a hair or a protein residue on the skin surface.
The functional group covalently bonded to the protein is selected from imide ester, aryl azide, diazyline, hydroxymethylphosphine, pentafluorophenyl ester, pyridyl disulfide, sulfo-hydroxy succinimide ester, alkoxyamine, hydrazide, The present invention relates to a process for the preparation of a compound of formula (I) as defined in claim 1, wherein the compound is selected from the group consisting of: haloacetyl, azide, carbonate, aldehyde, propionaldehyde, butylaldehyde, nitrophenylcarbonate, aziridine, isocyanate, thiocyanate, epoxide, Wherein the composition is at least one selected from the group consisting of oxycarbonylamidazole, imine, thiol, maleimide, vinylsulfone, ethyleneimine, thioether, acrylonitrile, acrylic acid or methacrylic acid ester, disulfide and ketone.
Wherein the carbodiimide compound is 0.001 to 10 parts by weight per 100 parts by weight of the total composition.
Wherein the carbodiimide compound and the body odor inhibiting component are formulated into a single agent in an encapsulated form or the carbodiimide compound and the body odor inhibitory component are separated from each other.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020130084718 | 2013-07-18 | ||
| KR20130084718 | 2013-07-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20150010551A true KR20150010551A (en) | 2015-01-28 |
| KR102006956B1 KR102006956B1 (en) | 2019-08-02 |
Family
ID=52482356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020130152361A KR102006956B1 (en) | 2013-07-18 | 2013-12-09 | Compositions for deodorant |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102006956B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102120835B1 (en) * | 2018-12-24 | 2020-06-09 | 재단법인 경남한방항노화연구원 | Natural deodorant composition using polyphenol |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002013773A2 (en) * | 2000-08-16 | 2002-02-21 | Unilever Plc | Cosmetic composition |
| KR20080064467A (en) | 2007-01-05 | 2008-07-09 | 주식회사 엘지생활건강 | Mixed-type personal care product for skin or hair |
| JP2008187928A (en) * | 2007-02-02 | 2008-08-21 | Yaizu Suisankagaku Industry Co Ltd | Body odor suppressing composition, and food and drink, cosmetics and washing treating agent containing the same, and body odor suppressing method |
-
2013
- 2013-12-09 KR KR1020130152361A patent/KR102006956B1/en active IP Right Grant
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002013773A2 (en) * | 2000-08-16 | 2002-02-21 | Unilever Plc | Cosmetic composition |
| KR20080064467A (en) | 2007-01-05 | 2008-07-09 | 주식회사 엘지생활건강 | Mixed-type personal care product for skin or hair |
| JP2008187928A (en) * | 2007-02-02 | 2008-08-21 | Yaizu Suisankagaku Industry Co Ltd | Body odor suppressing composition, and food and drink, cosmetics and washing treating agent containing the same, and body odor suppressing method |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102120835B1 (en) * | 2018-12-24 | 2020-06-09 | 재단법인 경남한방항노화연구원 | Natural deodorant composition using polyphenol |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102006956B1 (en) | 2019-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2780267C (en) | Compositions and methods for stimulating hair growth | |
| KR101453217B1 (en) | Cosmetics compositions for humectant | |
| KR102006948B1 (en) | Cosmetics compositions for skin whitening t | |
| KR102006952B1 (en) | Cosmetics compositions for prevention and improvement of wrinkle | |
| EP3388052A1 (en) | Functional composition for surface modification | |
| KR102006950B1 (en) | Cosmetics compositions for hair growth promoter | |
| WO2018099931A1 (en) | Anti-perspirant composition comprising chitosan | |
| EP3091961A1 (en) | Exfoliative hair retention-promoting formulation | |
| KR102486936B1 (en) | Cosmetics compositions for skin whitening | |
| KR20150066808A (en) | Compositions for nail-care | |
| JP5455292B2 (en) | Skin external composition | |
| JPH1017430A (en) | Irritation-preventing agent, and cosmetic containing the same for preventing irritation | |
| KR102006956B1 (en) | Compositions for deodorant | |
| JP4032246B2 (en) | White hair prevention and improvement agent | |
| KR102006951B1 (en) | Cosmetics compositions for prevention and improvement of dandruff or itching | |
| KR102502511B1 (en) | Cosmetics compositions for prevention and improvement of wrinkle | |
| KR20180108228A (en) | Cosmetics compositions for skin whitening | |
| KR102491996B1 (en) | Cosmetics compositions for prevention and improvement of wrinkle | |
| KR102491995B1 (en) | Cosmetics compositions for skin whitening | |
| KR102139148B1 (en) | Cosmetics compositions for hair growth inhibitor | |
| KR20150066827A (en) | Compositions for fragrance | |
| KR102075947B1 (en) | Cosmetics Compositions for atopic dermatitis or skin trouble care | |
| WO2019007790A1 (en) | Novel use | |
| KR102084521B1 (en) | Compositions for prevention and improvement of acne | |
| JP2001131025A (en) | Cosmetic for scalp and hair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |